Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Ibbotson

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Toxicology Letters|May 14, 2005
Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapyN J Traynor, P E Beattie, S H Ibbotson, et al.
The British Journal of Dermatology|September 21, 2021
A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen diseaseS H Ibbotson, J Ferguson, H Moseley, et al.
The British Journal of Dermatology|May 13, 2005
The effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53 activation and p21P E Beattie, L E Finlan, N M Kernohan, et al.
Contact Dermatitis|December 21, 2004
Can a positive photopatch test be elicited by subclinical irritancy or allergy plus suberythemal UV exposure?P E Beattie, N J Traynor, J A Woods, et al.
The British Journal of Dermatology|October 18, 2005
Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivoL E Finlan, N M Kernohan, G Thomson, et al.
The British Journal of Dermatology|June 28, 2003
A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasisR S Dawe, H Cameron, S Yule, et al.
The British Journal of Dermatology|November 26, 2005
Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?P E Beattie, R S Dawe, N J Traynor, et al.
Photodermatology, Photoimmunology & Photomedicine|April 12, 2006
Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivoS H Ibbotson, C Jong, A Lesar, et al.
The British Journal of Dermatology|August 3, 2006
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivoG Smith, S H Ibbotson, M M Comrie, et al.
The British Journal of Dermatology|October 6, 2007
Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapyG Smith, M J V Wilkie, Y Y Deeni, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Toxicology Letters|May 14, 2005
Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapyN J Traynor, P E Beattie, S H Ibbotson, et al.
The British Journal of Dermatology|September 21, 2021
A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen diseaseS H Ibbotson, J Ferguson, H Moseley, et al.
The British Journal of Dermatology|May 13, 2005
The effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53 activation and p21P E Beattie, L E Finlan, N M Kernohan, et al.
Contact Dermatitis|December 21, 2004
Can a positive photopatch test be elicited by subclinical irritancy or allergy plus suberythemal UV exposure?P E Beattie, N J Traynor, J A Woods, et al.
The British Journal of Dermatology|October 18, 2005
Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivoL E Finlan, N M Kernohan, G Thomson, et al.
The British Journal of Dermatology|June 28, 2003
A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasisR S Dawe, H Cameron, S Yule, et al.
The British Journal of Dermatology|November 26, 2005
Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?P E Beattie, R S Dawe, N J Traynor, et al.
Photodermatology, Photoimmunology & Photomedicine|April 12, 2006
Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivoS H Ibbotson, C Jong, A Lesar, et al.
The British Journal of Dermatology|August 3, 2006
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivoG Smith, S H Ibbotson, M M Comrie, et al.
The British Journal of Dermatology|October 6, 2007
Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapyG Smith, M J V Wilkie, Y Y Deeni, et al.
Pageof 10